Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 11/20 | 0.57 |
| ▸ | ADRB2 | P07550 | 7/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 17/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30488096 | 1.00 | ADRB1 (0.57) | ADRB1ADRB2ADRB3 | |
| SCHEMBL30488093 | 1.00 | ADRB1 (0.57) | ADRB1ADRB2ADRB3 | |
| SCHEMBL30488191 | 1.00 | ADRB1 (0.57) | ADRB1ADRB2ADRB3 | |
| SCHEMBL25226428 | 1.00 | ADRB1 (0.57) | ADRB1ADRB2ADRB3 | |
| SCHEMBL4053207 | 1.00 | ADRB1 (0.57) | ADRB1ADRB2ADRB3 | |
| SCHEMBL20819407 | 0.91 | ADRB1 (0.55) | ADRB1ADRB2ADRB3 | |
| SCHEMBL26177226 | 0.84 | ADRB3 (0.55) | ADRB1ADRB2ADRB3 | |
| SCHEMBL11746227 | 0.84 | ADRB1 (0.54) | ADRB1ADRB2ADRB3 | |
| SCHEMBL6320255 | 0.80 | SLC6A3 (0.55) | ADRB1ADRB2ADRB3 | |
| SCHEMBL4048311 | 0.80 | SLC6A3 (0.55) | ADRB1ADRB2ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339890-A1 | AMINO ALCOHOL COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| US-20230339890-A1 | AMINO ALCOHOL COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| US-20230339890-A1 | AMINO ALCOHOL COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. | 2023-10-26 | — | — | US | disclosed |
| WO-2023107630-A2 | AMINO ALCOHOL COMPOUNDS AND USES THEREOF | Kineta, Inc. (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023107630-A2 | AMINO ALCOHOL COMPOUNDS AND USES THEREOF | Kineta, Inc. (US) | 2023-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339890-A1 | AMINO ALCOHOL COMPOUNDS AND USES THEREOF | AADAT, SLC1A2, SLC1A1 | ADRB1 2287/4885ADRB2 2325/4885ADRB3 1624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.